SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

21 Aug 2024 Evaluate
The sales slipped to Rs. 2838.80 millions for the June 2024 quarter as against Rs. 3011.80 millions during the year-ago period.Net profit of the cmpany stood at Rs. 167.80 millions for the quarter ended June 2024 a decline of -43.73% from Rs. 298.20 millions  in the same quarter last year.A decline of 503.80 millions was observed in the OP in the quarter ended June 2024 from 508.00 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202406 202306 % Var
Sales 2838.80 3011.80 -5.74 11512.60 12296.20 -6.37 11512.60 12296.20 -6.37
Other Income 21.30 54.60 -60.99 156.30 183.90 -15.01 156.30 183.90 -15.01
PBIDT 503.80 508.00 -0.83 3216.30 3430.70 -6.25 3216.30 3430.70 -6.25
Interest 2.00 1.70 17.65 7.20 7.70 -6.49 7.20 7.70 -6.49
PBDT 299.90 506.30 -40.77 3007.20 3423.00 -12.15 3007.20 3423.00 -12.15
Depreciation 71.60 65.00 10.15 274.00 281.00 -2.49 274.00 281.00 -2.49
PBT 228.30 441.30 -48.27 2733.20 3142.00 -13.01 2733.20 3142.00 -13.01
TAX 60.50 143.10 -57.72 723.40 847.30 -14.62 723.40 847.30 -14.62
Deferred Tax -67.40 -8.00 742.50 -86.00 -50.60 69.96 -86.00 -50.60 69.96
PAT 167.80 298.20 -43.73 2009.80 2294.70 -12.42 2009.80 2294.70 -12.42
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 17.75 16.87 5.22 27.94 27.90 0.13 27.94 27.90 0.13

Procter&Gamble Healt Share Price

5021.30 29.00 (0.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×